Top compounds associated with response to RP11-226E21.4


Feature Type Standardized
Nominal ANOVA
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.075 0.07
mRNA thalidomide CTRPv2 pan-cancer AAC 0.099 0.07
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.067 0.08
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.056 0.08
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.068 0.08
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.08
mRNA N9-isopropylolomoucine CTRPv2 pan-cancer AAC 0.068 0.08
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.059 0.08
mRNA CIL41 CTRPv2 pan-cancer AAC -0.094 0.09
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.066 0.09
Download CSV